1	Vascular	Vascular	B-NP	JJ	B-protein	4	NMOD	-1
2	endothelial	endothelial	I-NP	JJ	I-protein	4	NMOD	-1
3	growth	growth	I-NP	NN	I-protein	4	NMOD	0
4	factor	factor	I-NP	NN	I-protein	13	NMOD	-1
5	(	(	O	(	O	7	DEP	-1
6	VEGF	VEGF	B-NP	NN	B-protein	7	DEP	-1
7	)	)	O	)	O	4	NMOD	-1
8	in	in	B-PP	IN	O	4	NMOD	-1
9	seizures	seizure	B-NP	NNS	O	8	PMOD	-1
10	:	:	O	:	O	4	P	-1
11	a	a	B-NP	DT	O	13	NMOD	-1
12	double-edged	double-edged	I-NP	JJ	O	13	NMOD	-1
13	sword	sword	I-NP	NN	O	0	ROOT	-1
14	.	.	O	.	O	13	P	-1

1	Vascular	Vascular	B-NP	JJ	B-protein	4	NMOD	-1
2	endothelial	endothelial	I-NP	JJ	I-protein	4	NMOD	-1
3	growth	growth	I-NP	NN	I-protein	4	NMOD	0
4	factor	factor	I-NP	NN	I-protein	8	SUB	-1
5	(	(	O	(	O	7	DEP	-1
6	VEGF	VEGF	B-NP	NN	B-protein	7	DEP	-1
7	)	)	O	)	O	4	NMOD	-1
8	is	be	B-VP	VBZ	O	0	ROOT	-1
9	a	a	B-NP	DT	O	12	NMOD	-1
10	vascular	vascular	I-NP	JJ	B-protein	12	NMOD	-1
11	growth	growth	I-NP	NN	I-protein	12	NMOD	0
12	factor	factor	I-NP	NN	I-protein	8	PRD	-1
13	which	which	B-NP	WDT	O	12	NMOD	-1
14	induces	induce	B-VP	VBZ	O	13	SBAR	17	induces
15	angiogenesis	angiogenesis	B-NP	NN	O	29	NMOD	3	angiogenesis
16	(	(	O	(	O	23	DEP	-1
17	the	the	B-NP	DT	O	18	NMOD	-1
18	development	development	I-NP	NN	O	23	DEP	2	development
19	of	of	B-PP	IN	O	18	NMOD	-1
20	new	new	B-NP	JJ	O	22	NMOD	-1
21	blood	blood	I-NP	NN	O	22	NMOD	-1
22	vessels	vessel	I-NP	NNS	O	19	PMOD	-1
23	)	)	O	)	O	15	NMOD	-1
24	,	,	O	,	O	29	P	-1
25	vascular	vascular	B-NP	JJ	O	26	NMOD	-1
26	permeability	permeability	I-NP	NN	O	29	NMOD	-1
27	,	,	O	,	O	29	P	-1
28	and	and	O	CC	O	29	NMOD	-1
29	inflammation	inflammation	B-NP	NN	O	14	OBJ	-1
30	.	.	O	.	O	8	P	-1

1	In	In	B-PP	IN	O	7	VMOD	-1
2	brain	brain	B-NP	NN	O	1	PMOD	-1
3	,	,	O	,	O	7	P	-1
4	receptors	receptor	B-NP	NNS	O	7	SUB	-1
5	for	for	B-PP	IN	O	4	NMOD	-1
6	VEGF	VEGF	B-NP	NN	B-protein	5	PMOD	-1
7	have	have	B-VP	VBP	O	0	ROOT	-1
8	been	be	I-VP	VBN	O	7	VC	-1
9	localized	localized	B-ADJP	JJ	O	14	NMOD	0
10	to	to	B-PP	TO	O	9	AMOD	-1
11	vascular	vascular	B-NP	JJ	O	12	NMOD	-1
12	endothelium	endothelium	I-NP	NN	O	10	PMOD	-1
13	,	,	O	,	O	9	P	-1
14	neurons	neuron	B-NP	NNS	O	8	PRD	-1
15	,	,	O	,	O	17	P	-1
16	and	and	O	CC	O	17	NMOD	-1
17	glia	glia	B-NP	NN	O	7	VMOD	-1
18	.	.	O	.	O	7	P	-1

1	VEGF	VEGF	B-NP	NN	B-protein	2	SUB	-1
2	is	be	B-VP	VBZ	O	0	ROOT	-1
3	upregulated	upregulate	I-VP	VBN	O	2	VC	17	upregulated
4	after	after	B-PP	IN	O	3	VMOD	-1
5	hypoxic	hypoxic	B-NP	JJ	O	6	NMOD	-1
6	injury	injury	I-NP	NN	O	4	PMOD	-1
7	to	to	B-PP	TO	O	6	NMOD	-1
8	the	the	B-NP	DT	O	9	NMOD	-1
9	brain	brain	I-NP	NN	O	7	PMOD	-1
10	,	,	O	,	O	2	P	-1
11	which	which	B-NP	WDT	O	2	VMOD	-1
12	can	can	B-VP	MD	O	11	SBAR	-1
13	occur	occur	I-VP	VB	O	12	VC	-1
14	during	during	B-PP	IN	O	13	VMOD	-1
15	cerebral	cerebral	B-NP	JJ	O	16	NMOD	-1
16	ischemia	ischemia	I-NP	NN	O	19	NMOD	-1
17	or	or	O	CC	O	19	NMOD	-1
18	high-altitude	high-altitude	B-NP	JJ	O	19	NMOD	-1
19	edema	edema	I-NP	NN	O	14	PMOD	-1
20	,	,	O	,	O	2	P	-1
21	and	and	O	CC	O	2	VMOD	-1
22	has	have	B-VP	VBZ	O	2	VMOD	-1
23	been	be	I-VP	VBN	O	22	VC	-1
24	implicated	implicate	I-VP	VBN	O	23	VC	0
25	in	in	B-PP	IN	O	24	VMOD	-1
26	the	the	B-NP	DT	O	29	NMOD	-1
27	blood-brain	blood-brain	I-NP	NN	O	29	NMOD	-1
28	barrier	barrier	I-NP	NN	O	29	NMOD	-1
29	breakdown	breakdown	I-NP	NN	O	25	PMOD	6	breakdown
30	associated	associate	B-VP	VBN	O	29	NMOD	0
31	with	with	B-PP	IN	O	30	VMOD	-1
32	these	these	B-NP	DT	O	33	NMOD	-1
33	conditions	condition	I-NP	NNS	O	31	PMOD	-1
34	.	.	O	.	O	2	P	-1

1	Given	Give	B-VP	VBN	O	11	VMOD	0
2	its	its	B-NP	PRP$	O	4	NMOD	-1
3	recently-described	recently-described	I-NP	JJ	O	4	NMOD	-1
4	role	role	I-NP	NN	O	1	OBJ	0
5	as	as	B-PP	IN	O	1	VMOD	-1
6	an	an	B-NP	DT	O	8	NMOD	-1
7	inflammatory	inflammatory	I-NP	JJ	B-protein	8	NMOD	-1
8	mediator	mediator	I-NP	NN	I-protein	5	PMOD	0
9	,	,	O	,	O	11	P	-1
10	VEGF	VEGF	B-NP	NN	B-protein	11	SUB	-1
11	could	could	B-VP	MD	O	0	ROOT	-1
12	also	also	I-VP	RB	O	11	VMOD	-1
13	contribute	contribute	I-VP	VB	O	11	VC	0
14	to	to	B-PP	TO	O	13	VMOD	-1
15	the	the	B-NP	DT	O	17	NMOD	-1
16	inflammatory	inflammatory	I-NP	JJ	O	17	NMOD	-1
17	responses	response	I-NP	NNS	O	14	PMOD	-1
18	observed	observe	B-VP	VBN	O	17	NMOD	0
19	in	in	B-PP	IN	O	18	VMOD	-1
20	cerebral	cerebral	B-NP	JJ	O	21	NMOD	-1
21	ischemia	ischemia	I-NP	NN	O	19	PMOD	-1
22	.	.	O	.	O	11	P	-1

1	After	After	B-PP	IN	O	9	VMOD	-1
2	seizures	seizure	B-NP	NNS	O	1	PMOD	-1
3	,	,	O	,	O	9	P	-1
4	blood-brain	blood-brain	B-NP	NN	O	6	NMOD	-1
5	barrier	barrier	I-NP	NN	O	6	NMOD	-1
6	breakdown	breakdown	I-NP	NN	O	8	NMOD	6	breakdown
7	and	and	I-NP	CC	O	8	NMOD	-1
8	inflammation	inflammation	I-NP	NN	O	9	SUB	-1
9	is	be	B-VP	VBZ	O	0	ROOT	-1
10	also	also	I-VP	RB	O	9	VMOD	-1
11	observed	observe	I-VP	VBN	O	9	VC	0
12	in	in	B-PP	IN	O	11	VMOD	-1
13	brain	brain	B-NP	NN	O	12	PMOD	-1
14	,	,	O	,	O	11	P	-1
15	albeit	albeit	B-ADVP	IN	O	11	VMOD	-1
16	on	on	B-PP	IN	O	15	PMOD	-1
17	a	a	B-NP	DT	O	19	NMOD	-1
18	lower	low	I-NP	JJR	O	19	NMOD	-1
19	scale	scale	I-NP	NN	O	16	PMOD	-1
20	than	than	B-PP	IN	O	19	NMOD	-1
21	that	that	B-NP	DT	O	20	PMOD	-1
22	observed	observe	B-VP	VBN	O	21	NMOD	0
23	after	after	B-PP	IN	O	22	VMOD	-1
24	stroke	stroke	B-NP	NN	O	23	PMOD	-1
25	.	.	O	.	O	9	P	-1

1	Recent	Recent	B-NP	JJ	O	2	NMOD	-1
2	evidence	evidence	I-NP	NN	O	3	SUB	-1
3	has	have	B-VP	VBZ	O	0	ROOT	-1
4	suggested	suggest	I-VP	VBN	O	3	VC	-1
5	a	a	B-NP	DT	O	6	NMOD	-1
6	role	role	I-NP	NN	O	4	OBJ	0
7	for	for	B-PP	IN	O	6	NMOD	-1
8	inflammation	inflammation	B-NP	NN	O	7	PMOD	-1
9	in	in	B-PP	IN	O	6	NMOD	-1
10	seizure	seizure	B-NP	NN	O	11	NMOD	-1
11	disorders	disorder	I-NP	NNS	O	9	PMOD	-1
12	.	.	O	.	O	3	P	-1

1	We	We	B-NP	PRP	O	2	SUB	-1
2	have	have	B-VP	VBP	O	0	ROOT	-1
3	described	describe	I-VP	VBN	O	2	VC	-1
4	striking	striking	B-NP	JJ	O	5	NMOD	-1
5	increases	increase	I-NP	NNS	O	3	OBJ	17	increases
6	in	in	B-PP	IN	O	5	NMOD	-1
7	VEGF	VEGF	B-NP	NN	B-protein	8	NMOD	-1
8	protein	protein	I-NP	NN	I-protein	6	PMOD	-1
9	in	in	B-PP	IN	O	5	NMOD	-1
10	both	both	B-NP	CC	O	13	NMOD	-1
11	neurons	neuron	I-NP	NNS	B-cell_type	13	NMOD	-1
12	and	and	I-NP	CC	O	13	NMOD	-1
13	glia	glia	I-NP	NNS	B-cell_type	9	PMOD	-1
14	after	after	B-PP	IN	O	5	NMOD	-1
15	pilocarpine-induced	pilocarpine-induced	B-NP	JJ	O	17	NMOD	-1
16	status	status	I-NP	NN	O	17	NMOD	-1
17	epilepticus	epilepticus	I-NP	NN	O	14	PMOD	-1
18	in	in	B-PP	IN	O	17	NMOD	-1
19	the	the	B-NP	DT	O	20	NMOD	-1
20	brain	brain	I-NP	NN	O	18	PMOD	-1
21	.	.	O	.	O	2	P	-1

1	Increases	Increase	B-NP	NNS	O	4	SUB	17	Increases
2	in	in	B-PP	IN	O	1	NMOD	-1
3	VEGF	VEGF	B-NP	NN	B-protein	2	PMOD	-1
4	could	could	B-VP	MD	O	0	ROOT	-1
5	contribute	contribute	I-VP	VB	O	4	VC	17	contribute
6	to	to	B-PP	TO	O	5	VMOD	-1
7	the	the	B-NP	DT	O	12	NMOD	-1
8	blood-brain	blood-brain	I-NP	JJ	O	10	NMOD	-1
9	barrier	barrier	I-NP	NN	O	10	NMOD	-1
10	breakdown	breakdown	I-NP	NN	O	12	NMOD	6	breakdown
11	and	and	I-NP	CC	O	12	NMOD	-1
12	inflammation	inflammation	I-NP	NN	O	6	PMOD	-1
13	observed	observe	B-VP	VBN	O	12	NMOD	0
14	after	after	B-PP	IN	O	13	VMOD	-1
15	seizures	seizure	B-NP	NNS	O	14	PMOD	-1
16	.	.	O	.	O	4	P	-1

1	However	However	B-ADVP	RB	O	4	VMOD	-1
2	,	,	O	,	O	4	P	-1
3	VEGF	VEGF	B-NP	NN	B-protein	4	SUB	-1
4	has	have	B-VP	VBZ	O	0	ROOT	-1
5	also	also	I-VP	RB	O	4	VMOD	-1
6	been	be	I-VP	VBN	O	4	VC	-1
7	shown	show	I-VP	VBN	O	6	VC	-1
8	to	to	I-VP	TO	O	9	VMOD	-1
9	be	be	I-VP	VB	O	7	VMOD	-1
10	neuroprotective	neuroprotective	B-ADJP	JJ	O	9	PRD	-1
11	across	across	B-PP	IN	O	10	AMOD	-1
12	several	several	B-NP	JJ	O	14	NMOD	-1
13	experimental	experimental	I-NP	JJ	O	14	NMOD	-1
14	paradigms	paradigm	I-NP	NNS	O	11	PMOD	-1
15	,	,	O	,	O	4	P	-1
16	and	and	O	CC	O	4	VMOD	-1
17	hence	hence	B-VP	RB	O	4	VMOD	-1
18	could	could	I-VP	MD	O	4	VMOD	-1
19	potentially	potentially	I-VP	RB	O	18	VMOD	-1
20	protect	protect	I-VP	VB	O	18	VC	18	protect
21	vulnerable	vulnerable	B-NP	JJ	B-cell_type	22	NMOD	-1
22	cells	cell	I-NP	NNS	I-cell_type	20	OBJ	-1
23	from	from	B-PP	IN	O	20	VMOD	-1
24	damage	damage	B-NP	NN	O	23	PMOD	6	damage
25	associated	associate	B-VP	VBN	O	24	NMOD	0
26	with	with	B-PP	IN	O	25	VMOD	-1
27	seizures	seizure	B-NP	NNS	O	26	PMOD	-1
28	.	.	O	.	O	4	P	-1

1	Therefore	Therefore	B-ADVP	RB	O	0	ROOT	-1
2	,	,	O	,	O	1	P	-1
3	the	the	B-NP	DT	O	4	NMOD	-1
4	role	role	I-NP	NN	O	2	SUB	0
5	of	of	B-PP	IN	O	4	NMOD	-1
6	VEGF	VEGF	B-NP	NN	B-protein	5	PMOD	-1
7	after	after	B-SBAR	IN	O	4	DEP	-1
8	seizures	seizure	B-NP	NNS	O	9	SUB	-1
9	could	could	B-VP	MD	O	7	SBAR	-1
10	be	be	I-VP	VB	O	9	VC	-1
11	either	either	O	CC	O	14	AMOD	-1
12	protective	protective	B-ADJP	JJ	O	14	AMOD	-1
13	or	or	I-ADJP	CC	O	14	AMOD	-1
14	destructive	destructive	I-ADJP	JJ	O	10	PRD	-1
15	.	.	O	.	O	4	P	-1

1	Although	Although	B-SBAR	IN	O	19	VMOD	-1
2	only	only	B-NP	RB	O	4	NMOD	-1
3	further	far	I-NP	JJR	O	4	NMOD	-1
4	research	research	I-NP	NN	O	5	SUB	-1
5	will	will	B-VP	MD	O	1	SBAR	-1
6	determine	determine	I-VP	VB	O	5	VC	-1
7	the	the	B-NP	DT	O	9	NMOD	-1
8	exact	exact	I-NP	JJ	O	9	NMOD	-1
9	nature	nature	I-NP	NN	O	6	OBJ	-1
10	of	of	B-PP	IN	O	9	NMOD	-1
11	VEGF	VEGF	B-NP	NN	B-protein	12	NMOD	-1
12	's	's	B-NP	POS	O	13	NMOD	-1
13	role	role	I-NP	NN	O	10	PMOD	0
14	after	after	B-PP	IN	O	13	NMOD	-1
15	seizures	seizure	B-NP	NNS	O	14	PMOD	-1
16	,	,	O	,	O	19	P	-1
17	preliminary	preliminary	B-NP	JJ	O	18	NMOD	-1
18	data	datum	I-NP	NNS	O	19	SUB	-1
19	indicate	indicate	B-VP	VBP	O	0	ROOT	-1
20	that	that	B-SBAR	IN	O	19	VMOD	-1
21	VEGF	VEGF	B-NP	NN	B-protein	22	SUB	-1
22	plays	play	B-VP	VBZ	O	20	SBAR	-1
23	a	a	B-NP	DT	O	25	NMOD	-1
24	protective	protective	I-NP	JJ	O	25	NMOD	-1
25	role	role	I-NP	NN	O	22	OBJ	0
26	after	after	B-PP	IN	O	22	VMOD	-1
27	seizures	seizure	B-NP	NNS	O	26	PMOD	-1
28	.	.	O	.	O	19	P	-1

